Cargando…
At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+(high) T-Cell Fraction
BACKGROUND: In experimental models, Type 1 diabetes T1D can be prevented by adoptive transfer of CD4+CD25+ FoxP3+ suppressor or regulatory T cells. Recent studies have found a suppression defect of CD4+CD25+(high) T cells in human disease. In this study we measure apoptosis of CD4+CD25+(high) T cell...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1764033/ https://www.ncbi.nlm.nih.gov/pubmed/17206281 http://dx.doi.org/10.1371/journal.pone.0000146 |
_version_ | 1782131581466443776 |
---|---|
author | Glisic-Milosavljevic, Sanja Waukau, Jill Jailwala, Parthav Jana, Srikanta Khoo, Huoy-Jii Albertz, Hope Woodliff, Jeffrey Koppen, Marilyn Alemzadeh, Ramin Hagopian, William Ghosh, Soumitra |
author_facet | Glisic-Milosavljevic, Sanja Waukau, Jill Jailwala, Parthav Jana, Srikanta Khoo, Huoy-Jii Albertz, Hope Woodliff, Jeffrey Koppen, Marilyn Alemzadeh, Ramin Hagopian, William Ghosh, Soumitra |
author_sort | Glisic-Milosavljevic, Sanja |
collection | PubMed |
description | BACKGROUND: In experimental models, Type 1 diabetes T1D can be prevented by adoptive transfer of CD4+CD25+ FoxP3+ suppressor or regulatory T cells. Recent studies have found a suppression defect of CD4+CD25+(high) T cells in human disease. In this study we measure apoptosis of CD4+CD25+(high) T cells to see if it could contribute to reduced suppressive activity of these cells. METHODS AND FINDINGS: T-cell apoptosis was evaluated in children and adolescent 35 females/40 males subjects comprising recent-onset and long-standing T1D subjects and their first-degree relatives, who are at variable risk to develop T1D. YOPRO1/7AAD and intracellular staining of the active form of caspase 3 were used to evaluate apoptosis. Isolated CD4+CD25+(high) and CD4+CD25− T cells were co-cultured in a suppression assay to assess the function of the former cells. We found that recent-onset T1D subjects show increased apoptosis of CD4+CD25+(high) T cells when compared to both control and long-standing T1D subjects p<0.0001 for both groups. Subjects at high risk for developing T1D 2–3Ab+ve show a similar trend p<0.02 and p<0.01, respectively. On the contrary, in long-standing T1D and T2D subjects, CD4+CD25+(high) T cell apoptosis is at the same level as in control subjects p = NS. Simultaneous intracellular staining of the active form of caspase 3 and FoxP3 confirmed recent-onset FoxP3+ve CD4+CD25+(high) T cells committed to apoptosis at a higher percentage 15.3±2.2 compared to FoxP3+ve CD4+CD25+(high) T cells in control subjects 6.1±1.7 p<0.002. Compared to control subjects, both recent-onset T1D and high at-risk subjects had significantly decreased function of CD4+CD25+(high) T cells p = 0.0007 and p = 0.007, respectively. CONCLUSIONS: There is a higher level of ongoing apoptosis in CD4+CD25+(high) T cells in recent-onset T1D subjects and in subjects at high risk for the disease. This high level of CD4+CD25+(high) T-cell apoptosis could be a contributing factor to markedly decreased suppressive potential of these cells in recent-onset T1D subjects. |
format | Text |
id | pubmed-1764033 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-17640332007-01-05 At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+(high) T-Cell Fraction Glisic-Milosavljevic, Sanja Waukau, Jill Jailwala, Parthav Jana, Srikanta Khoo, Huoy-Jii Albertz, Hope Woodliff, Jeffrey Koppen, Marilyn Alemzadeh, Ramin Hagopian, William Ghosh, Soumitra PLoS One Research Article BACKGROUND: In experimental models, Type 1 diabetes T1D can be prevented by adoptive transfer of CD4+CD25+ FoxP3+ suppressor or regulatory T cells. Recent studies have found a suppression defect of CD4+CD25+(high) T cells in human disease. In this study we measure apoptosis of CD4+CD25+(high) T cells to see if it could contribute to reduced suppressive activity of these cells. METHODS AND FINDINGS: T-cell apoptosis was evaluated in children and adolescent 35 females/40 males subjects comprising recent-onset and long-standing T1D subjects and their first-degree relatives, who are at variable risk to develop T1D. YOPRO1/7AAD and intracellular staining of the active form of caspase 3 were used to evaluate apoptosis. Isolated CD4+CD25+(high) and CD4+CD25− T cells were co-cultured in a suppression assay to assess the function of the former cells. We found that recent-onset T1D subjects show increased apoptosis of CD4+CD25+(high) T cells when compared to both control and long-standing T1D subjects p<0.0001 for both groups. Subjects at high risk for developing T1D 2–3Ab+ve show a similar trend p<0.02 and p<0.01, respectively. On the contrary, in long-standing T1D and T2D subjects, CD4+CD25+(high) T cell apoptosis is at the same level as in control subjects p = NS. Simultaneous intracellular staining of the active form of caspase 3 and FoxP3 confirmed recent-onset FoxP3+ve CD4+CD25+(high) T cells committed to apoptosis at a higher percentage 15.3±2.2 compared to FoxP3+ve CD4+CD25+(high) T cells in control subjects 6.1±1.7 p<0.002. Compared to control subjects, both recent-onset T1D and high at-risk subjects had significantly decreased function of CD4+CD25+(high) T cells p = 0.0007 and p = 0.007, respectively. CONCLUSIONS: There is a higher level of ongoing apoptosis in CD4+CD25+(high) T cells in recent-onset T1D subjects and in subjects at high risk for the disease. This high level of CD4+CD25+(high) T-cell apoptosis could be a contributing factor to markedly decreased suppressive potential of these cells in recent-onset T1D subjects. Public Library of Science 2007-01-03 /pmc/articles/PMC1764033/ /pubmed/17206281 http://dx.doi.org/10.1371/journal.pone.0000146 Text en Glisic-Milosavljevic et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Glisic-Milosavljevic, Sanja Waukau, Jill Jailwala, Parthav Jana, Srikanta Khoo, Huoy-Jii Albertz, Hope Woodliff, Jeffrey Koppen, Marilyn Alemzadeh, Ramin Hagopian, William Ghosh, Soumitra At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+(high) T-Cell Fraction |
title | At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+(high) T-Cell Fraction |
title_full | At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+(high) T-Cell Fraction |
title_fullStr | At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+(high) T-Cell Fraction |
title_full_unstemmed | At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+(high) T-Cell Fraction |
title_short | At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+(high) T-Cell Fraction |
title_sort | at-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the cd4+cd25+(high) t-cell fraction |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1764033/ https://www.ncbi.nlm.nih.gov/pubmed/17206281 http://dx.doi.org/10.1371/journal.pone.0000146 |
work_keys_str_mv | AT glisicmilosavljevicsanja atriskandrecentonsettype1diabeticsubjectshaveincreasedapoptosisinthecd4cd25hightcellfraction AT waukaujill atriskandrecentonsettype1diabeticsubjectshaveincreasedapoptosisinthecd4cd25hightcellfraction AT jailwalaparthav atriskandrecentonsettype1diabeticsubjectshaveincreasedapoptosisinthecd4cd25hightcellfraction AT janasrikanta atriskandrecentonsettype1diabeticsubjectshaveincreasedapoptosisinthecd4cd25hightcellfraction AT khoohuoyjii atriskandrecentonsettype1diabeticsubjectshaveincreasedapoptosisinthecd4cd25hightcellfraction AT albertzhope atriskandrecentonsettype1diabeticsubjectshaveincreasedapoptosisinthecd4cd25hightcellfraction AT woodliffjeffrey atriskandrecentonsettype1diabeticsubjectshaveincreasedapoptosisinthecd4cd25hightcellfraction AT koppenmarilyn atriskandrecentonsettype1diabeticsubjectshaveincreasedapoptosisinthecd4cd25hightcellfraction AT alemzadehramin atriskandrecentonsettype1diabeticsubjectshaveincreasedapoptosisinthecd4cd25hightcellfraction AT hagopianwilliam atriskandrecentonsettype1diabeticsubjectshaveincreasedapoptosisinthecd4cd25hightcellfraction AT ghoshsoumitra atriskandrecentonsettype1diabeticsubjectshaveincreasedapoptosisinthecd4cd25hightcellfraction |